Mónica L. Guzmán

13.2k total citations · 5 hit papers
150 papers, 7.4k citations indexed

About

Mónica L. Guzmán is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Mónica L. Guzmán has authored 150 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Molecular Biology, 76 papers in Hematology and 33 papers in Oncology. Recurrent topics in Mónica L. Guzmán's work include Acute Myeloid Leukemia Research (69 papers), CAR-T cell therapy research (18 papers) and Histone Deacetylase Inhibitors Research (15 papers). Mónica L. Guzmán is often cited by papers focused on Acute Myeloid Leukemia Research (69 papers), CAR-T cell therapy research (18 papers) and Histone Deacetylase Inhibitors Research (15 papers). Mónica L. Guzmán collaborates with scholars based in United States, Mexico and Israel. Mónica L. Guzmán's co-authors include Craig T. Jordan, Mark Noble, Dianna S. Howard, Randall M. Rossi, Duane C. Hassane, Gail J. Roboz, Barry Grimes, Sarah J. Neering, David A. Rizzieri and Selina M. Luger and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Mónica L. Guzmán

140 papers receiving 7.3k citations

Hit Papers

Cancer Stem Cells 2001 2026 2009 2017 2006 2001 2005 2018 2019 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cancer Stem Cells
    2006 1.4k citations Craig T. Jordan, Mónica L. Guzmán et al. profile →
  2. Nuclear factor-κB is constitutively activated in primitive human acute myelogenous leukemia cells
    2001 592 citations Mónica L. Guzmán, Barry Grimes et al. Blood profile →
  3. The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells
    2005 546 citations Mónica L. Guzmán, Randall M. Rossi et al. Blood profile →
  4. Somatic mutations precede acute myeloid leukemia years before diagnosis
    2018 384 citations Pinkal Desai, Nuria Mencia-Trinchant et al. Nature Medicine profile →
  5. FDA-approved ferumoxytol displays anti-leukaemia efficacy against cells with low ferroportin levels
    2019 254 citations Vicenta Trujillo-Alonso, Hongliang Zong et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mónica L. Guzmán United States 40 4.2k 2.2k 2.2k 1.7k 1.1k 150 7.4k
Andrew P. Mazar United States 53 3.5k 0.8× 2.3k 1.0× 1.3k 0.6× 3.0k 1.7× 908 0.9× 176 7.8k
Martin Sattler United States 55 4.3k 1.0× 2.4k 1.1× 3.1k 1.4× 764 0.4× 1.2k 1.2× 151 8.6k
Michael Ploug Denmark 55 3.1k 0.7× 2.2k 1.0× 2.3k 1.0× 4.7k 2.7× 964 0.9× 157 8.8k
Richard B. Lock Australia 53 5.1k 1.2× 2.8k 1.3× 1.6k 0.7× 1.2k 0.7× 1.0k 0.9× 260 8.7k
Michelle A. Rudek United States 48 3.8k 0.9× 2.5k 1.1× 947 0.4× 1.2k 0.7× 359 0.3× 239 7.2k
William S. Dalton United States 59 6.8k 1.6× 5.7k 2.6× 2.4k 1.1× 2.3k 1.3× 2.3k 2.1× 132 11.8k
Anne‐Marie Mes‐Masson Canada 50 4.4k 1.0× 2.7k 1.2× 741 0.3× 1.9k 1.1× 1.3k 1.2× 272 9.1k
Pierfrancesco Tassone Italy 65 7.5k 1.8× 3.9k 1.8× 2.9k 1.3× 3.8k 2.2× 1.6k 1.6× 317 11.8k
Raymond Lai Canada 56 4.7k 1.1× 4.8k 2.1× 828 0.4× 1.6k 0.9× 1.7k 1.6× 262 11.1k
Thomas Meyer Switzerland 45 3.7k 0.9× 2.2k 1.0× 1.5k 0.7× 668 0.4× 459 0.4× 137 7.9k

Countries citing papers authored by Mónica L. Guzmán

Since Specialization
Citations

This map shows the geographic impact of Mónica L. Guzmán's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mónica L. Guzmán with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mónica L. Guzmán more than expected).

Fields of papers citing papers by Mónica L. Guzmán

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mónica L. Guzmán. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mónica L. Guzmán. The network helps show where Mónica L. Guzmán may publish in the future.

Co-authorship network of co-authors of Mónica L. Guzmán

This figure shows the co-authorship network connecting the top 25 collaborators of Mónica L. Guzmán. A scholar is included among the top collaborators of Mónica L. Guzmán based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mónica L. Guzmán. Mónica L. Guzmán is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guzmán, Mónica L., et al.. (2024). Experimental Testing of Tall Slender Masonry Walls with Different Rotational Base Stiffnesses. Journal of Structural Engineering. 150(3). 1 indexed citations
2.
Ghram, Mehdi, Biljana Culjkovic‐Kraljacic, Jean-Clément Mars, et al.. (2023). The eukaryotic translation initiation factor eIF4E reprograms alternative splicing. The EMBO Journal. 42(7). e110496–e110496. 15 indexed citations
3.
Παπαδοπούλου, Αθανασία, Leandro Marcelo Martinez, Victoria Campbell, et al.. (2023). P1350: M2-LIKE MONOCYTE-DERIVED MACROPHAGES PROTECT AML CELL LINES AND PRIMARY AML CELLS AGAINST THERAPY-INDUCED APOPTOSIS. HemaSphere. 7(S3). e92103ee–e92103ee.
4.
Sugita, Mayumi, Takahiro Yamazaki, Leandro Marcelo Martinez, et al.. (2023). Low Dose Total Body Irradiation Improves CD19 CAR-T Expansion, Persistence, and Trafficking, Leading to Enhanced Efficacy in Large B-Cell Lymphoma. Blood. 142(Supplement 1). 1016–1016. 2 indexed citations
5.
Sugita, Mayumi, Takahiro Yamazaki, J. Martinet, et al.. (2023). Radiation therapy improves CAR T cell activity in acute lymphoblastic leukemia. Cell Death and Disease. 14(5). 305–305. 22 indexed citations
6.
Osman, Afaf E.G., Nuria Mencia-Trinchant, Caner Saygin, et al.. (2022). Paired bone marrow and peripheral blood samples demonstrate lack of widespread dissemination of some CH clones. Blood Advances. 7(9). 1910–1914. 8 indexed citations
7.
Patel, Sanjay S., Julia T. Geyer, Joelle Racchumi, et al.. (2021). Comparison of Multiple Clinical Testing Modalities for Assessment of NPM1-Mutant AML. Frontiers in Oncology. 11. 701318–701318. 13 indexed citations
8.
Mencia-Trinchant, Nuria, Matthew MacKay, Christopher R. Chin, et al.. (2020). Clonal Hematopoiesis Before, During, and After Human Spaceflight. Cell Reports. 33(10). 108458–108458. 36 indexed citations
9.
Yamazaki, Tomoo, Mayumi Sugita, J. Martinet, et al.. (2020). Boosting CAR T Cell Expansion and Therapeutic Activity with Low-dose Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 108(3). S158–S159. 5 indexed citations
10.
Sharma, Krishan K., William F. Reynolds, Raúl G. Enríquez, et al.. (2020). Synthesis, Crystallography, and Anti-Leukemic Activity of the Amino Adducts of Dehydroleucodine. Molecules. 25(20). 4825–4825. 6 indexed citations
11.
Johnson, Matthew, et al.. (2019). Mitophagy Plays a Key Role in the Anti-Leukemic Activity of Autophagy Inhibitors Under Hypoxia in Acute Myeloid Leukemia. Blood. 134(Supplement_1). 1278–1278. 12 indexed citations
12.
Kourtis, Nikos, Charalampos Lazaris, Kathryn Hockemeyer, et al.. (2018). Oncogenic hijacking of the stress response machinery in T cell acute lymphoblastic leukemia. Nature Medicine. 24(8). 1157–1166. 58 indexed citations
13.
Baran, Natalia, Shannon Sweeney, Alessia Lodi, et al.. (2017). Inhibition of Oxphos with Iacs-010759 Depletes AML Leukemia Initiating Cells (LIC) in Vitro and Improves Survival in Pre-Clinical AML Models. Blood. 130. 1350–1350. 1 indexed citations
14.
Mencia-Trinchant, Nuria, Yang Hu, Bas J. Wouters, et al.. (2017). Minimal Residual Disease Monitoring of Acute Myeloid Leukemia by Massively Multiplex Digital PCR in Patients with NPM1 Mutations. Journal of Molecular Diagnostics. 19(4). 537–548. 60 indexed citations
15.
Ho, Tzu‐Chieh, Mark W. LaMere, Brett M. Stevens, et al.. (2016). Evolution of acute myelogenous leukemia stem cell properties after treatment and progression. Blood. 128(13). 1671–1678. 166 indexed citations
16.
Guzmán, Mónica L., Mayumi Sugita, Hongliang Zong, et al.. (2016). Allogeneic Tcrα/β Deficient CAR T-Cells Targeting CD123 Prolong Overall Survival of AML Patient-Derived Xenografts. Blood. 128(22). 765–765. 13 indexed citations
17.
Guzmán, Mónica L., Neng Yang, Krishan K. Sharma, et al.. (2014). Selective Activity of the Histone Deacetylase Inhibitor AR-42 against Leukemia Stem Cells: A Novel Potential Strategy in Acute Myelogenous Leukemia. Molecular Cancer Therapeutics. 13(8). 1979–1990. 45 indexed citations
18.
Neelakantan, Sundar, Shama Nasim, Mónica L. Guzmán, Craig T. Jordan, & Peter A. Crooks. (2009). Aminoparthenolides as novel anti-leukemic agents: Discovery of the NF-κB inhibitor, DMAPT (LC-1). Bioorganic & Medicinal Chemistry Letters. 19(15). 4346–4349. 149 indexed citations
19.
Hassane, Duane C., Mónica L. Guzmán, Cheryl A. Corbett, et al.. (2008). Discovery of agents that eradicate leukemia stem cells using an in silico screen of public gene expression data. Blood. 111(12). 5654–5662. 145 indexed citations
20.
Guzmán, Mónica L., Carol Swiderski, Dianna S. Howard, et al.. (2002). Preferential induction of apoptosis for primary human leukemic stem cells. Proceedings of the National Academy of Sciences. 99(25). 16220–16225. 334 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrew P. Mazar Breakdown of academic impact, for papers by Martin Sattler Breakdown of academic impact, for papers by Michael Ploug Breakdown of academic impact, for papers by Richard B. Lock Breakdown of academic impact, for papers by Michelle A. Rudek Breakdown of academic impact, for papers by William S. Dalton Breakdown of academic impact, for papers by Anne‐Marie Mes‐Masson Breakdown of academic impact, for papers by Pierfrancesco Tassone Breakdown of academic impact, for papers by Raymond Lai Breakdown of academic impact, for papers by Thomas Meyer
Rankless by CCL
2026